The development of the jaw joint between the palatoquadrate and proximal part Meckel's cartilage (articular) has recently been shown to involve the gene Bapx1. Bapx1 is expressed in the developing mandibular arch in two distinct caudal, proximal patches, one on either side of the head. These domains coincide later with the position of the developing jaw joint. The mechanisms that result in the restricted expression of Bapx1 in the mandibular arch were investigated, and two signaling factors that act as repressors were identified. Fibroblast growth factors (Fgfs) expressed in the oral epithelium restrict expression of Bapx1 to the caudal half of the mandibular arch, while bone morphogenetic proteins (Bmps) expressed in the distal mandibular arch restrict expression of Bapx1 to the proximal part of the mandible. Application of Fgf8 and Bmp4 beads to the proximal mesenchyme led to loss of Bapx1 expression and later fusion of the quadrate and articular as the jaw joint failed to form. In addition to fusion of the jaw joint, loss of Bapx1 lead to loss of the retroarticular process (RAP), phenocopying the defects seen after Bapx1 function was reduced in the zebrafish. By manipulating these signals, we were able to alter the expression domain of Bapx1, resulting in a new position of the jaw joint. D
Introduction
Bapx1, also known as Nkx3.2, is the vertebrate homologue of the Drosophila gene Bagpipe. A member of the NK2 class of homeobox genes, Bagpipe has been shown to play a role in the specification of the musculature of the embryonic midgut (Azpiazu and Frasch, 1993) . In vertebrates, Bagpipe homologues have been cloned in Xenopus, mouse, chick, and zebrafish (Miller et al., 2003; Newman et al., 1997; Schneider et al., 1999; Tribioli et al., 1997) , and it appears that the genes' role in the developing gut musculature has been evolutionary conserved throughout these groups. In addition, the vertebrate homologues show expression of Bapx1 in the craniofacial region. In Xenopus and zebrafish, Bapx1 (Xbap) expression in the facial mesenchyme has been shown to mark the precursors of the palatoquadrate and proximal Meckel's cartilage, along with the basihyal (Miller et al., 2003; Newman et al., 1997) . The quadrate region of the palatoquadrate and proximal end of Meckel's cartilage (the articular) form the jaw joint in all gnathostomes, except the Mammalia, providing the articulation between the upper and lower jaws (Figs. 1A, B) . Morpholinos against Bapx1 in zebrafish embryos lead to a fusion of the jaw joint, and loss of the retroarticular process (RAP) and retroarticular bone, showing the importance of this gene for jaw joint development, and development of skeletal elements associated with the jaw joint (Miller et al., 2003) . In the zebrafish, Bapx1 expression has been shown to be positively regulated by endothelin-1, to the extent that the expression of Bapx1 in the presumptive jaw joint is lost in the endothelin-1 mutant (known as sucker) (Miller et al., 2003) . Endothelin-1 is found in the epithelium and mesoderm core of the branchial arches, while endothelin receptors are localized to the neural crest (Clouthier et al., 1998) . Endothelin-1 has been shown to be necessary for the maintenance of some genes, such as dHand, Dlx3, and Gsc, all of which have very different expression patterns (Clouthier et al., 2000; Miller et al., 2000 ; Thomas et al., 1998; Tucker et al., 1999) . It is therefore difficult to see how the expression of endothelin-1 can account for the highly restricted expression pattern of Bapx1 in the first branchial arch. We have investigated the mechanisms that result in the restricted expression of Bapx1 in the mandible using the chick as our model system.
The mesenchymal expression domain of Bapx1 in the chick first branchial arch first appears at E4 (stage 24) restricted to the proximal -caudal region. Removal of the epithelium before this stage results in no induction of Bapx1 expression. Removal of the epithelium at E4 results in downregulation of expression, indicating the loss of some maintenance factor in the epithelium. However, in conjunction with the reduction in expression, loss of the epithelium also leads to an expansion in expression pattern. Thus, the epithelium would appear to express some factors that act to inhibit the normal expression of Bapx1. We have identified members of the fibroblast growth factor (Fgf) and bone morphogenetic protein (Bmp) family of signaling factors as potential endogenous inhibitors, which act to restrict expression of Bapx1 to the proximal -caudal region of the mandible. A negative role for Fgfs in regulating gene expression is particularly interesting given the fact that Fgf signaling to date has only been linked to a positive role in inducing gene expression in the developing mandible (Barlow et al., 1999; Ferguson et al., 2000; Grigoriou et al., 1998; Mandler and Neubüser, 2001; Mina et al., 2002; Neubüser et al., 1997; Tucker et al., 1998 Tucker et al., , 1999 .
Fgf8 is a signaling molecule known to have an important role in regulating the rostral -caudal axis of the first branchial arch (Tucker et al., 1999) . It is expressed in the rostral (oral) epithelium of the first branchial arch and is known to positively regulate the expression of the homeobox genes Lhx6/7, Barx1, Gsc, and Dlx (Ferguson et al., 2000; Grigoriou et al., 1998; Tucker et al., 1998 Tucker et al., , 1999 . In the Fgf8 crelox knock out mice, where Fgf8 is inactivated specifically in the first arch epithelium, expressions of Lhx6, Gsc, and Barx1 are lost in the branchial arch, resulting in loss of the cartilage elements of the first arch, except for those at the most distal tip (Trumpp et al., 1999) . Fgf9, which has a similar expression pattern in the face to Fgf8, induces many of the same genes as Fgf8, and it appears that Fgf9 may compensate for the loss of Fgf8 in the cre-lox mice with regards to the formation of the distal regions of the mandible (Mandler and Neubüser, 2001; Trumpp et al., 1999) . Fgfr1-3 are expressed in the developing chick mandible, with Fgfr2 and 3 showing a restricted expression pattern overlapping with Bapx1 in the caudal mesenchyme (Mina et al., 2002; Wilke et al., 1997) . Previously, Fgf8 has been shown to negatively regulate the expression of Bapx1 at the level of Hensen's node at stage 4 in the chick, where Bapx1 has an asymmetrical expression (Schneider et al., 1999) .
Bmp4 is a signaling molecule known to have an important role in regulating the proximo-distal axis of the first branchial arch. It is expressed initially in the distal region of the mandible in the rostral (oral) epithelium, adjacent to the expression domain of Fgf8. As well as positively regulating the expression of the homeobox genes Msx1 and Msx2 in the distal mesenchyme, Bmp4 acts to negatively regulate the (D) In sagittal section, the signal can be seen to be localized to the epithelium (ectoderm and endoderm) surrounding the proximal part of each arch. There is no expression in the mesenchyme at this stage. (E) Bapx1 expression at E4 (stage 24). A new expression domain is now seen in the first branchial arch slightly distal to the expression in the epithelium. (F) In sagittal section, the signal can be seen to be localized to the caudal region of the first arch, as indicated by the arrow. (G) Frontal view of Bapx1 expression at E4.5 (stage 26). Expression is seen strongly in the caudal first arch in two proximal patches, underlying expression in the oral cavity. (H) Side view of embryo at E6. Arrows point to epithelial expression in the oral cavity and in the developing external ear. Axes are indicated by arrows, R = rostral, C = caudal, P = proximal, and D = distal. Orientation of B -F, H as for A. expression of other more proximally expressed homeobox genes, such as Barx1 (Barlow et al., 1999; Tucker et al., 1998) . Removal of Bmp signaling by the use of the Bmp antagonist Noggin in the mouse leads to loss of the distally expressed genes and upregulation of Barx1 in the distal region. In mouse mandible cultures, this results in the transformation of incisors to a molar phenotype . We have manipulated the expression of Bapx1 using Fgfs and Bmps and their inhibitors and looked at the effect on the jaw joint.
Materials and methods

In situ hybridization
Paraffin wax sections were cut at 8 Am and split over three to five slides, then prepared for radioactive 35 S in situ hybridization, as previously described by Tucker et al. (1999) .
Serial sections were stained with hematoxylin -eosin (Sigma) to visualize the tissue morphology. Digoxigenin whole-mount in situ hybridization was performed as described in Pownall et al. (1996) . Whole-mount embryos were embedded in 80% gelatin and refixed in 4% paraformaldehyde before vibratome sectioning at 30 Am.
Chick Bapx1 was cloned using a stage 10 -12 whole embryo cDNA library using PCR primers (Genosis) to the chick gene (, AF138905). Chick Bapx1 was linearized with Not1 and transcribed with T3. Chick Gdf5 was linearized with Pst1 and transcribed with T7. Chick Fgf8 was linearized with BamHI and transcribed with T7. Chick Barx1 was linearized with EcoRI and transcribed with T7. Chick Msx1 was linearized with BglII and transcribed with T3. Chick dHand was linearized with XbaI and transcribed with T7.
Removal of epithelium
Chick mandibles were dissected out in Tyrodes at E3, E3.75-E4, and E4.75-E5 and washed in calcium -magnesium-free PBS. Mandibles were placed in filtered Dispase (2 U/ml Gibco) at 37jC for 10 -15 min depending on size, and then the epithelium was teased off using tungsten needles. Mandibles with or without epithelium were floated onto millipore filters and cultured on metal grids in a CO 2 incubator at 37jC for 24 h in DMEM + 10% Fetal Calf serum + antibiotic -antimycotic (Gibco BRL). Cultures were fixed in ice-cold methanol for a minute before being moved to 4% paraformaldehyde. Cultures were left overnight in the fridge then dehydrated in MeOH and stored at À 20jC.
Inhibition of Fgf signaling
A stock solution of the Fgf inhibitor SU5402 (Calbiochem) was made up in DMSO to 50 mM and stored at À 20jC.
Facial processes were dissected out at E3.75-E4 and E4.75-E5 and cultured as detailed above. Control cultures were cultured in DMEM plus 1% DMSO and experimental cultures had SU5402 added to the medium at concentrations ranging from 5 to 100 AM. For long-term culture of facial processes, the facial processes were dissected and cultured as detailed in Hu and Helms (2001) .
Fgf8, Bmp4, and Noggin beads
Heparin beads were soaked overnight at 4jC in Fgf8 protein (R&D systems) at 1 mg/ml or BSA 100 Ag/ml for control beads. Beads were implanted in caudal proximal mesenchyme at E4 and E5 in cultures of facial processes or in ovo (see below). Affigel-blue beads (Biorad) were washed in PBS and completely dried under lights. Beads were then left to soak in Bmp4 or Noggin protein (R&D Systems) at 100 Ag/ml at 37jC for 30 min. Bmp4 beads were placed in caudal proximal mesenchyme at E4 in cultures of facial processes or in ovo, while Noggin beads were placed more distally within the embryos in culture or in ovo at E3 and E4.
In ovo culture
Chick eggs were incubated on their sides and windowed at E2. Eggs were then incubated further until E4 to E6 ready for implantation of beads. Once at the appropriate stage, eggs were reopened and the membranes around the head pulled apart to allow access to the arches. India ink diluted 1:5 with Tyrodes was injected into the yolk just under the embryo to allow better visibility of the head region. Fgf8 and Bmp4 beads were implanted into the caudal region of the first branchial arch, in the protuberance designated as 'b' by Hamburger and Hamilton (1951) . Noggin beads were implanted more distally in the region designated as 'c' by Hamburger and Hamilton (1951) . At E3 (stage 20), Noggin beads were placed distally within the developing mandible. In each case, beads were implanted on the right-hand side of the embryo. Survival was approximately 90% after 24 h, reducing to 60% after 7 days. Embryos were fixed overnight in 4% paraformaldehyde. Embryos were then either dehydrated in methanol for storage at À 20jC until in situ hybridization or were stained for cartilage. Embryos for sectioning were embedded in wax via isopropanol and tetrahydronaphthalene.
Cartilage and bone staining E7 to E10 heads were dissected to remove the eyes, skin, and brain. They were then washed and stained overnight in 100 mg/1-l Alcian Blue (Gurr Certistain), in 70% EtOH, 30% acetic acid. Heads were then destained in 95% EtOH and slowly rehydrated. Once in H 2 O, heads were cleared in 1% KOH and photographed. For bone stain, cartilage stained embryos were placed in a 1% alizarin red solution in 0.5% KOH O/N and washed in 1% KOH.
Immunohistochemistry
Type II collagen staining was performed using the II-II6B3 antibody (Developmental Studies Hybridoma Bank) on paraffin wax sections from E5 to E7. To enhance the signal, the slides were microwaved in 0.01 M citrate buffer (Shi et al., 1991) and treated with chondroteinase ABC (0.25 units/ml) and hyaluronidase (1.45 units/ml) at 37jC for 45 min (Sigma). The collagen antibody supernatant was used at a dilution of 1:100.
Results
Expression of Bapx1 in the forming jaw joint
In the chick, expression of Bapx1 (Nkx3.2) has only been followed up to E4 (stage 24), and therefore, its expression in the forming jaw joint has not been assessed (Schneider et al., 1999) . We therefore, carried out a series of in situ hybridizations between E3 (stage 20) and E9. At E3 (stage 20), Bapx1 is strongly expressed in the epithelium of the pharyngeal arches, as has previously been described (Schneider et al., 1999) (Figs. 1C, D) . By E4 (stage 24), a new expression domain is seen in the caudal -proximal region of the first branchial arch in the underlying mesenchyme (Figs. 1E, F). This expression domain becomes very intense by E4.5 (stage 26) ( Fig. 1G ). At this stage, expression is very clear in the oral epithelium, and more proximally at the junction between the first and second arch where the first pharyngeal cleft will form (data not shown). Later at E6 (stage 29), the epithelial expression in between the first and second arch labels the developing external ear (Fig. 1H) .
At E6.5 (stage 30) the quadrate and Meckel's cartilage appear as a single condensation expressing type II collagen (Figs. 2A, B) . Type II collagen is a marker of the onset of overt cartilage differentiation (von der Mark et al., 1976) , and its production proceeds in a wave starting at the quadrate at E5.75 and moving into Meckel's cartilage. Bapx1 is expressed in the caudal end of the quadrate and proximal part of Meckel's cartilage, the articular (Fig. 2C) . By E7 to E7.5 (stage 31), the quadrate and Meckel's cartilage are observed as two distinct cartilages, and the jaw joint can be seen by type II collagen immunos (Figs. 2D, E) and in Alcian blue preparations (Fig. 1A) . No apoptosis (programmed cell death) was observed in the developing joint region (data not shown). Bapx1 remains expressed in the quadrate and articular part of Meckel's, but also in the jaw joint itself (Fig. 2F) . From E7 to E9, expression of Bapx1 has started to downregulate in the cartilages themselves but remains high in the joint region (data not shown).
The caudal restriction of mesenchymal Bapx1 expression is controlled by the epithelium
The epithelium was removed from mandibles at E3 (before expression of Bapx1 in the mesenchyme), E4 (after mesenchymal expression of Bapx1 is initiated), and E5 (once expression of Bapx1 is established). The mandibles were then cultured for 24 h. Whole mandibles dissected out at E3 and cultured for 24 h showed clear expression in the oral epithelium (rostrally) and expression in the mesenchyme (caudally) (Fig. 3A) . When the epithelium was removed, no expression of Bapx1 was induced in the mesenchyme after culture, indicating the presence of an inducer of Bapx1 residing in the epithelium (Fig. 3B ). At E4, when the epithelium was removed, the expression of Bapx1 was maintained, but at lower levels than in cultures with epithelium (Figs. 3C, D) . This reduced level indicates the presence of a maintenance signal for Bapx1 in the epithelium at this stage. Endothelin-1 is expressed in the branchial arch epithelium and has been shown to positively regulate Bapx1 expression in the zebrafish (Miller et al., 2003) . The reduced expression of Bapx1 after removal of the epithelium may therefore represent a reduction in endothelin-1 signaling. In addition, however, the expression pattern of Bapx1 was altered and now spread out from the caudal mesenchyme towards the rostral mesenchyme, and in some cases was seen to span the whole rostral -caudal axis (Figs. 3C, D) . Interestingly, no spread was observed along the proximo-distal axis, so that expression of Bapx1 was confined to a thin streak. At E5, the expression domain of Bapx1 was unaffected by loss of the epithelium and remained restricted to the caudal mesenchyme (Figs. 3E, F) . The mesenchymal expression of Bapx1 is thus independent of the epithelium by this stage. A shift in dependency on signals from the epithelium is seen for some genes expressed in the mandibular mesenchyme (Ferguson et al., 2000) . The rostral spread after removal of the epithelium indicates the existence of an inhibitor to Bapx1 expression in the epithelium. In the branchial arches, Fgf8 and Fgf9 are expressed in the rostral (oral) epithelium at a distance from the mesenchymal expression domain of Bapx1 (Figs. 3G, H: only Fgf8 is shown). Both Fgfs are therefore good candidates for the endogenous repressor of Bapx1 expression in rostral mesenchyme. As Fgf8 protein has been shown to down- regulate Bapx1 expression in early development (Schneider et al., 1999) , we have used Fgf8 in this set of experiments, but Fgf9 may have a similar effect. To test the ability of Fgf8 to repress Bapx1 expression, the epithelium was removed and Fgf8 beads were placed in the rostral mesenchyme. This caused the expression of Bapx1 to remain restricted to the caudal mesenchyme on the side with the bead, while the expression of Bapx1 extended rostrally on the non-bead side (Fig. 3I ). Control BSA beads had no effect on expression. In some cases, the Fgf8 bead was placed slightly more caudally, and in these examples, the mesenchymal expression domain of Bapx1 was dramatically reduced (Fig. 3J ), indicating that Fgf8 can indeed repress Bapx1.
Inhibition of Fgf signaling causes a caudal to rostral shift of mesenchymal Bapx1
In order to test further whether Fgfs could be responsible for the effect seen after removal of the epithelium, a block to Fgf signaling, SU5402, was added to cultures of facial processes. SU5402 is an oxoindole derivative that blocks signaling by binding to the nucleotide binding site of FGF receptors. SU5402 has previously been used to block FGF signaling in a variety of developmental processes (Mandler and Neubüser, 2001; Norlin et al., 2000; Schneider et al., 1999; Wilson et al., 2000) . At E4, 25 AM concentration of inhibitor caused a shift in expression of Bapx1 from the caudal mesenchyme to the rostral mesenchyme, in line with the effect seen after removal of the epithelium (Figs. 4A, B) . At 5-10 AM SU5402, no effect was observed (data not shown). At E5, no effect was seen after addition of the inhibitor, mimicking the result seen after removal of the epithelium (Figs. 4C, D) . No effect was seen in control cultures with DMSO. High levels of Fgf from the rostral epithelium thus appear to be inhibiting expression of Bapx1 in the underlying mesenchyme, and reduction in Fgf signaling by removing the epithelial source of Fgf8 or by use of an inhibitor leads to a rostral shift in expression. When treated cultures were left for longer periods, the global loss of Fgf signaling from E4 had major consequences for facial development, with the mandibular and maxillary arches regressing completely after 3 days in culture (Figs. 4E, F) . The effect was tissue specific as eye development appeared relatively unaffected in cultures after this time. In cultures treated with the Fgf block for 24 h and then left to develop in control medium for 48 h, the development of the facial processes was also completely disrupted (data not shown). Fgf signaling is therefore critical for development of the first branchial arch at E4. As the effect of blocking Fgf signaling is so devastating, we were unable to assess the effect of the rostral shift of Bapx1 expression on cartilage development and jaw joint positioning. 
Fgf8 inhibits expression of Bapx1 in the mesenchyme
Fgf8 beads were then placed in the caudal proximal mesenchyme in cultured facial processes at E4. After 24 h, the mesenchymal expression of Bapx1 was completely abolished on the operated side (Fig. 5A) . Fgf8, therefore, does appear to repress expression of Bapx1. When similar experiments were carried out in ovo, the same complete repression of mesenchymal Bapx1 expression was observed (Figs. 5B,  D) . BSA control beads had no effect (data not shown). When the experiments were repeated in culture or in ovo at E5, however, no repression was seen (data not shown). The mesenchymal expression of Bapx1 is thus no longer sensitive to Fgf signaling by this stage. It has previously been shown that Fgf8 beads implanted in proximal (lateral) mandibular mesenchyme were unable to stimulate apoptosis, proliferation, or chondrogenesis in this region at E3.5 (Mina et al., 2002) . The effect of Fgf8 on Bapx1, therefore, is unlikely to be a result of cell death in the region surrounding the bead. At this stage, however, Fgf8 beads placed in proximal mesenchyme minus epithelium were able to induce expression of Msx1, which normally has an expression domain restricted to the distal mesenchyme of the branchial arches (Mina et al., 2002) . However, at stage 24 in ovo, proximally placed Fgf8 beads had no effect on Msx1 expression (Fig. 4E) , agreeing with similar results by Mina et al. (2002) . In addition to Msx1, dHand, a transcription factor that is also restricted to the distal mesenchyme of the branchial arches and Bmp4, which positively regulates the expression of Msx1, were also unaffected by the Fgf8 bead ( Fig. 5F and data not shown).
Addition of Fgf8, and loss of Bapx1, leads to loss of the jaw joint
In order to assess the effect of Fgf8 induced loss of Bapx1 on jaw joint formation, beads were again implanted into proximal caudal mesenchyme from E4 onwards, and this time the embryos were left to develop for several days. At E8, when the jaw joint is clearly visible, the quadrate and Meckel's cartilage remained fused in those embryos where Fgf8 beads had been added at E4 (Figs. 6A, B) . In embryos where beads were added from E5 onwards, no such fusion was observed, and instead, a distinct quadrate and Meckel's could be seen (data not shown). There is thus a very clear correlation between loss of Bapx1 after Fgf8 bead treatment and loss of the jaw joint and maintenance of Bapx1 after Fgf8 bead treatment and formation of the jaw joint. Gdf5 has been proposed as a downstream target for Bapx1 as it is lost after treatment with Bapx1 morpholinos in the zebrafish. We therefore looked at the effect on Gdf5 expression in these Fgf8 bead experiments. Gdf5 is expressed at high levels in between the quadrate and articular part of Meckel's from E7.0, as the jaw joint is starting to form. Expression is also seen around the cartilages of the face throughout their length, and so the expression domain appears not to be as restricted as that seen in the zebrafish (data not shown). After the addition of Fgf8 beads to the proximal -caudal mesenchyme at E4, no Gdf5 expression was seen between the fused quadrate and articular on the operated side (Fig.  6C) . Normal expression between these elements was observed on the control side (Fig. 6D) . Expression of Gdf5, however, was maintained around the cartilages of the face on the side treated with Fgf8. The loss of Gdf5 is therefore specific to the small domain that represents the forming jaw joint.
The embryos were then left to develop up to E10 to establish that the defect in the joint was not simply due to a delay in its formation. The E10 heads were stained for Alcian blue to show up the developing cartilages. Along with a fused quadrate and Meckel's cartilage, the embryos showed loss of the retroarticular process and a failure for the quadratojugal to articulate with the quadrate (Figs. 6E -J) . The rest of the head appeared relatively unaffected by the bead implantation (Figs. 6E, F) . The retroarticular process (RAP) is derived from second arch neural crest cells (Köntges and Lumsden, 1996) . This group of cells should not be directly affected by the Fgf8 beads, which were placed in the first branchial arch. In the normal situation, the first arch derived articular (the proximal part of Meckel's cartilage) forms first and then the retroarticular process is laid down at the most proximal tip. When the jaw joint fuses after Fgf8 treatment, the articular fails to form correctly, which then appears to have a secondary effect on the formation of the RAP. Loss of RAP was a prominent feature of the zebrafish embryos where Bapx1 had been knocked down (Miller et al., 2003) . The phenotype we observed after addition of Fgf8 beads at E4 is thus identical to that reported after direct loss of Bapx1 in zebrafish. The fusion of the jaw joint not only affects the articular, but the caudal part of the quadrate is also misshapen. This means that the quadratojugal, which normally articulates with this region, is unable to secure its position and instead terminates far from the quadrate in the majority of cases (Figs. 6G, H) . The quadratojugal connects the lower and upper jaws. Fusion of the jaw joint therefore results in isolation of the upper and lower beak.
Bmp signaling inhibits Bapx1 expression
The mesenchymal expression domain of Bapx1 is not only restricted along the rostral caudal axis, but is also restricted along the proximo-distal axis, and this restriction is maintained even after removal of the epithelium. Restriction of other homeobox genes to the proximal region of the mandible has previously been shown to involve Bmps . At E4 (stage 24), Bmp4 is expressed in the distal epithelium (Fig. 7A) , while Bmp2 is also expressed in the distal mesenchyme (data not shown). The expression patterns of these two genes in mandible development have been previously shown in detail (Francis-West et al., 1994) . To test whether Bmp signaling could indeed be responsible for restriction of Bapx1 to the proximal mandible, Bmp4 beads were placed in the caudal proximal mesenchyme. Bmp4 beads resulted in complete loss of Bapx1 in a similar manner to that seen previously for Barx1 (Barlow et al., 1999) . Both genes appeared very sensitive to addition of Bmp4, and complete loss of expression was observed (Figs. 7B, C) . In addition to loss of Bapx1 and Barx1, the expression of Msx1, a distal marker, was now extended proximally around the bead (Fig. 7D) , agreeing with the results of Barlow and Fig. 6H ). The quadratojugal however has formed an attachment with the quadrate. In addition, an ectopic membranous bone is seen to connect the quadratojugal with the surangular, resulting in a new connection between the upper and lower jaw (arrow head). Qj = quadratojugal, Q = quadrate, M = Meckel's cartilage, S = surangular. Francis-West (1997) . No similar expansion of dHand, however, was observed (data not shown). Bmp4 has been shown to inhibit the expression of Fgf8 in mouse mandible cultures (Stottmann et al., 2001 ). We therefore looked at the expression of Fgf8 after addition of Bmp4 beads proximally. When Bmp4 beads were placed caudally within the arch, a slight reduction in expression of Fgf8 could be observed in the rostral epithelium. However, when the Bmp4 beads were placed more rostrally, complete loss of Fgf8 expression was observed (Fig. 7E) . Addition of Bmp4 beads proximally thus results in loss of proximally expressed genes and an increase of some distally expressed genes.
When this experiment was repeated in ovo and the embryos were left to develop to E10, the quadrate was found fused to Meckel's cartilage in a similar manner to that seen after addition of Fgf8 beads (Fig. 7F) . Thus, the addition of two different signaling factors to the proximal, caudal mesenchyme of the mandible resulted in loss of Bapx1 and loss of the jaw joint. Defects in jaw joint development have previously been noted after the addition of Bmp2 or Bmp7 beads to the chick proximal mandible at E4 (Barlow and Francis-West, 1997; Wang et al., 1999) . Unlike the examples of fused jaw joint seen after the addition of Fgf8 beads (see Figs. 6G -I ), the quadratojugal did form an attachment in 3/4 cases. In addition, in one case, an ectopic membraneous bone was seen connecting the quadratojugal and the surangular, resulting in a new link between the upper and lower jaws (arrowhead in Fig. 7F ).
Inhibition of Bmp signaling at E3 but not E4 leads to ectopic Bapx1 expression distally
To test further whether Bmp signaling could be responsible for Bapx1 restriction to proximal mesenchyme, beads soaked in the Bmp antagonist Noggin were added to distal mesenchyme. Noggin has been used to antagonize Bmp signaling in some systems (McMahon et al., 1998; . It might be predicted that inhibition of Bmp signaling in this region would lead to expansion of Bapx1 into the distal region. Noggin soaked beads were added at two stages: E3, before the initial induction of Bapx1 in the mesenchyme, and at E4, after the induction of Bapx1 in the mesenchyme. At E3, addition of Noggin beads to the distal region of the developing mandible lead to an expansion of the Bapx1 domain distally towards the bead after 30 h in culture (Fig. 8A) . Interestingly, if beads were placed rostrally, near the oral epithelium, no extension in this direction was seen (data not shown). In addition to an expansion of Bapx1 distally, Noggin beads resulted in loss of dHand and Msx1 expression around the bead (Fig. 8B and data not shown). As Bmp signaling antagonizes Fgf8, we looked at the effect of Noggin beads on Fgf8 expression. In each case, Noggin beads result in an expansion of the Fgf8 expression domain distally (Fig. 8C) . Noggin beads thus result in a shift of expression of proximally expressed genes distally and loss of distally expressed genes. The expansion of Fgf8 expression explains why the expression of Bapx1 does not extend rostrally as well as distally after the addition of Noggin beads (Fig. 8A) . When the experiment was repeated at E4, no effect of Noggin beads on Bapx1 expression was evident (Fig. 8D) . This indicates that the distal mesenchyme may not be competent to express Bapx1 at this stage. Competence of mandibular mesenchyme to respond to signaling factors has previously been shown to be highly dependent on stage (Ferguson et al., 2000; Mandler and Neubüser, 2001 ). In conjunction with this, no effect on the expression of dHand, Fgf8, or Msx1 was observed (Figs. 8E, F and data not shown).
When Noggin beads were added distally at E3 in ovo and left to develop to E10, two defects were immediately apparent. Firstly, the jaw was completely skewed over to the side with the bead, due to a shortening of Meckel's cartilage (Figs. 8G, H), and secondly, the articular was altered in shape (Fig.  8I) . The actual jaw joint between quadrate and articular, however, remained intact, as would be predicted given the fact that Bapx1 was still expressed in the mesenchyme. It is tempting to speculate that the change in shape of the articular cartilage is due to the change in expression pattern of Bapx1, which now encompasses a much larger region. At this stage in development, Bmps have a role in stimulating chondrogenesis in the distal region of the mandibular process (Mina et al., 2002) , and addition of Bmp2, 4, or 7 beads distally results in formation of ectopic cartilage (Barlow and Francis-West, 1997; Mina et al., 2002) . This, therefore, may account for the shortening of Meckel's cartilage seen after the addition of Noggin beads. However, the position of the Noggin beads in relation to the resulting structures is not indicative of this being the main reason for the skewed face. In each case, the Noggin bead, which was initially placed distally in the mandible, was now positioned at or very near the jaw joint rather than more distally within the body of Meckel's cartilage (see arrows Figs. 8H, I ). This indicates that the position of the actual jaw joint has moved distally to coincide with the position of the bead. As the quadrate still manages to articulate with the quadratojugal and pterygoid membranous bones, the result is a skewed face.
When Noggin beads were implanted distal to the endogenous Bapx1 domain at E4 in ovo and cultured to E10, no effect was seen on jaw joint development (data not shown). At this stage in development, Bmps are unable to affect the growth of the mandibular process (Wang et al., 1999) ; thus, it is not surprising that there was no effect on growth of Meckel's cartilage after addition of Noggin at this stage.
Discussion
Regulation of Bapx1 expression
In a recent paper, Bapx1 has been shown to be required for the formation of the jaw joint. The expression of Bapx1 was shown to be positively regulated by endothelin-1, which is expressed in the surrounding branchial arch epithelium and in the mesoderm core (Clouthier et al., 1998; Miller et al., 2003) . In the zebrafish, careful analysis has shown that the expression of endothelin-1 in the epithelium is restricted ventrally (distally with respect to this paper) (Miller et al., 2003) ; this restriction, however, has yet to be observed in mouse or chick. In the zebrafish endothelin-1 mutant (known as sucker), Meckel's cartilage is fused to the palatoquadrate (Kimmel et al., 2001; Miller et al., 2000) , and expression of Bapx1 is lost (Miller et al., 2003) . In the chick, treatment with endothelin-1 antagonists leads to a reduction in the size of Meckel's cartilage, the defect appearing most severe at the most proximal regions (Kempf et al., 1998) . In the mouse, loss of endothelin-1 or its receptor leads to loss of Meckel's cartilage, along with more proximal structures, such as the malleus, incus, and tympanic ring (Clouthier et al., 1998; Kurihara et al., 1994) .
In this paper, we have described how the expression of Bapx1 might be restricted to the caudal proximal mesenchyme of the mandibular process of the first arch. Removal of the epithelium at E4 leads to a spread of expression from the caudal to rostral axis, although no spread was seen along the proximo-distal axis. Not all the mandibular mesenchyme, therefore, appears competent to express Bapx1 after removal of the epithelium. The caudal to rostral spread can be blocked by the addition of Fgf8 beads. A complete shift in expression from the caudal to rostral mesenchyme can be induced by the addition of antagonists to Fgf signaling. Bapx1 mesenchymal expression can be completely abolished by the addition of Fgf8 beads to the caudal mesenchyme. Fgf8 (or Fgf9) is therefore a good candidate for the endogenous repressor of Bapx1, restricting its expression to the caudal mesenchyme. The proximal restriction of Bapx1 appears to be under the control of Bmp signaling. Bmp4 beads placed proximally lead to complete loss of Bapx1 expression. Noggin beads can expand the expression domain of Bapx1 distally if placed in the distal mesenchyme at E3. Positioning of the mesenchymal expression domain of Bapx1, therefore, seems to involve negative signaling by members of the Fgf and Bmp family of signaling molecules.
The influence of the Fgfs and Bmps on Bapx1 expression is carefully controlled over time. At E3, Fgf8 and Bmp4 signaling from the oral epithelium established the proxi-mal -distal and rostral -caudal axes with regard to the expression of Msx1 and Barx1. Noggin beads added at this time lead to loss of Bmp signaling, and a corresponding expansion of Fgf8 signaling. As the expression of Fgf8 expands, many genes positively regulated by Fgf8 (such as Barx1), or negatively regulated by Bmps (such as Bapx1), also expand their expression domains distally, while genes positively regulated by the Bmps (such as Msx1) are lost. At E4, the expression patterns become more fixed, such that the Fgf8 expression domain cannot be expanded into the distal region after the addition of Noggin beads. However, the endogenous expression domain of Fgf8 can still be inhibited at this stage by the addition of Bmp4 beads placed proximally. This then results in the loss of proximal markers (such as Barx1 and Bapx1) and upregulation of distal markers (such as Msx1). By E5, the expression domains of the homeobox genes are completely fixed, and removal of the epithelium has no effect on the spatially restricted expression domains of the homeobox genes in the underlying mesenchyme. A similar progression and change in competence has been shown in the mouse mandible (Ferguson et al., 2000) .
In zebrafish, the expression of Bapx1 appears to be negatively regulated by the transcription factor dHand, such that in the dHand mutant, Bapx1 expression extends more ventrally (distally in the context of this paper) (Miller et al., 2003) . In the chick, dHand expression is restricted to the distal mesenchyme of the branchial arches (Clouthier et al., 2000) . Unlike Bapx1, its expression is not restricted to the first branchial arch; however, in the first arch, it shows a complementary expression pattern to that of Bapx1. In the sympathetic neurons and gut, the expression of dHand has been shown to be induced by Bmps (Howard et al., 2000; Wu and Howard, 2002 ). Here we show that the addition of the BMP antagonist Noggin at E3 leads to loss of dHand expression. It is possible that the expansion of Bapx1 observed after treatment with Noggin at E3 acts via the removal of dHand from the distal mesenchyme. Interestingly, however, Bmp4 beads added proximally at E4 were unable to induce ectopic dHand. This may indicate that the proximal mesenchyme is not competent to express dHand at this stage, or that another Bmp family member is responsible for activation and maintenance of dHand.
At E3, removal of the epithelium results in a failure of Bapx1 to be induced in the mesenchyme after 24-30 h in culture. Removal of the epithelium at E4 results in a downregulation of Bapx1 expression. A positive regulator of Bapx1 signaling must thus reside in the epithelium covering the first branchial arch. In addition to endothelin-1, other signaling molecules have been implicated in the positive regulation of Bapx1. In chick presomitic mesoderm, sonic hedgehog (Shh) is able to induce strong expression of Bapx1 (Murtaugh et al., 2001) . Expression of Bapx1 in the presomitic mesoderm, once induced by Shh, can be maintained by the addition of Bmp4. In our mandible experiments, Bmp4 was found to inhibit mesenchymal Bapx1 expression; thus, the signals that regulate Bapx1 expression appear to have different roles in different tissues. The regulation of Bapx1 by Shh appears to work via Pax1 and Pax9. Bapx1 expression is lost in the sclerotome in Pax1-Pax9 mutant mice; however, the mandibular expression domain is unaffected (Rodrigo et al., 2003) . In the chick branchial arches, Shh is expressed in the pharyngeal endoderm and posterior endoderm of the second branchial arch (Wall and Hogan, 1995) ; however, it is not expressed near to the mesenchymal Bapx1 domain. Thus, while Shh appears to play a role in regulating Bapx1 expression in the sclerotome, it is unlikely to play a role in mandibular Bapx1 regulation.
Manipulation of Bapx1 expression leads to changes in development and position of the jaw joint Indirect loss of Bapx1, by addition of Fgf8 or Bmp4 beads at E4, leads to fusion of the quadrate and Meckel's cartilages, and loss of the jaw joint. The defects observed mimic those reported when morpholinos have been used to reduce Bapx1 function in the zebrafish, confirming the role of Bapx1 in nonmammalian vertebrate jaw development. In both cases, the jaw joint never forms and the articular and quadrate remain a single cartilaginous element. From the earliest onset of Alcian blue staining, the quadrate and articular region of Meckel's cartilage are seen as two separate cartilages (Fig. 1A) , however, a different pattern is observed after immunohistochemistry for type II collagen (Fig. 2) . Interestingly, not only do the quadrate and Meckel's cartilage initially develop from a single condensation, but this condensation produces type II collagen throughout the region at E6.5. Just a few hours later at E7.0, a clear gap is visible between the two cartilage elements; however, no apoptosis is seen. The jaw joint thus represents a group of cells that start on a chondrogenic pathway, but then switch off production of ECM components to allow formation of a gap between the quadrate and articular.
In addition, we have shown that a distal expansion of Bapx1, after addition of Noggin beads distally at E3, leads to alterations in the shape of the articular and position of the jaw joint. The distally placed Noggin beads are in each case at the position of the jaw joint, implying that the jaw joint (quadrate and articular) has formed distally. The quadrate has then still managed to attach itself to the upper jaw (via the quadratojugal and pterygoid) resulting in a skewed face. Expression of Bapx1 appears, therefore, to control the position of the jaw joint within the first arch. As Bapx1 is expressed long before cartilage differentiation, it may be that Bapx1 lies as the start of a joint making hierarchy, controlling where the quadrate, articular, and joint will form in the developing head. In support of this, Gdf5, a gene well known to have a role in digit joint formation (Storm and Kingsley, 1999; Storm et al., 1994) , is lost in the jaw joint after loss of Bapx1 in the zebrafish (Miller et al., 2003) . In the chick, Gdf5 is also expressed between the developing quadrate and articular. Indirect loss of Bapx1 by repression from Fgf8 beads leads to loss of this specific domain of Gdf5 expression as the jaw joint fails to form. Gdf5 is thus a good marker for jaw joint development.
Bapx1 has been knocked out in the mouse by three groups (Akazawa et al., 2000; Lettice et al., 1999; Tribioli and Lufkin, 1999) . In each case, the same phenotype is observed involving defects to the axial skeleton, spleen, and cranial bones of mesodermal origin. No defect has been observed in the jaw joint. The lack of a jaw joint defect is not surprising as the mammalian jaw has a separate origin, when compared to that of all other gnathostomes, and now forms between the squamosal and dentary membranous bones. According to Reichert's theory, the primary (primitive) jaw joint discussed in this paper is represented in mammals as an articulation site between the incus and malleus bones of the middle ear, known as the incudomallear joint (Reichert, 1837) . The incus is homologous to the quadrate and the malleus is homologous to the articular. It would be interesting to assess whether there is a defect in articulation between the incus and malleus in these knockout mice.
